(Q38308978)

English

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

scientific article published on 29 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

oligosaccharide

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Yutaka Kanda

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Tsuyoshi Yamada

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Katsuhiro Mori

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Akira Okazaki

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Miho Inoue

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kazuko Kitajima-Miyama

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Reiko Kuni-Kamochi

7

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Ryosuke Nakano

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Keiichi Yano

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Shingo Kakita

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Kenya Shitara

11

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Mitsuo Satoh

12

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

29 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

104-118

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Crystallographic structure of an intact IgG1 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Crystallographic structure studies of an IgG molecule and an Fc fragment

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Glycosylation of recombinant antibody therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Interaction sites on human IgG-Fc for FcgammaR: current models

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Evidence for a role of accessible galactosyl or mannosyl residues of Fc domain in the in vivo clearance of IgG antibody-coated autologous erythrocytes in the rat.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

A high-throughput microscale method to release N-linked oligosaccharides from glycoproteins for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

The structure of a human type III Fcgamma receptor in complex with Fc

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Two Chinese hamster ovary glycosylation mutants affected in the conversion of GDP-mannose to GDP-fucose

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Comparability testing of a humanized monoclonal antibody (Synagis) to support cell line stability, process validation, and scale-up for manufacturing

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Control of carbohydrate processing: the lec1A CHO mutation results in partial loss of N-acetylglucosaminyltransferase I activity

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-->6fucosyltransferase.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWL057

21 January 2018

Identifiers

10.1093/GLYCOB/CWL057

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38308978&oldid=1752938717"